Globus Medical EBIT 2010-2025 | GMED
Globus Medical annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
- Globus Medical EBIT for the quarter ending March 31, 2025 was $0.097B, a 1113% increase year-over-year.
- Globus Medical EBIT for the twelve months ending March 31, 2025 was $0.255B, a 200.93% increase year-over-year.
- Globus Medical 2024 annual EBIT was $0.166B, a 24.67% increase from 2023.
- Globus Medical 2023 annual EBIT was $0.133B, a 41.59% decline from 2022.
- Globus Medical 2022 annual EBIT was $0.228B, a 32.57% increase from 2021.
| Globus Medical Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $166 |
| 2023 | $133 |
| 2022 | $228 |
| 2021 | $172 |
| 2020 | $111 |
| 2019 | $172 |
| 2018 | $169 |
| 2017 | $162 |
| 2016 | $154 |
| 2015 | $172 |
| 2014 | $138 |
| 2013 | $102 |
| 2012 | $115 |
| 2011 | $97 |
| 2010 | $88 |
| 2009 | $82 |
| Globus Medical Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2025-03-31 | $97 |
| 2024-12-31 | $60 |
| 2024-09-30 | $48 |
| 2024-06-30 | $50 |
| 2024-03-31 | $8 |
| 2023-12-31 | $10 |
| 2023-09-30 | $0 |
| 2023-06-30 | $66 |
| 2023-03-31 | $56 |
| 2022-12-31 | $54 |
| 2022-09-30 | $60 |
| 2022-06-30 | $68 |
| 2022-03-31 | $46 |
| 2021-12-31 | $18 |
| 2021-09-30 | $53 |
| 2021-06-30 | $46 |
| 2021-03-31 | $55 |
| 2020-12-31 | $59 |
| 2020-09-30 | $50 |
| 2020-06-30 | $-26 |
| 2020-03-31 | $28 |
| 2019-12-31 | $50 |
| 2019-09-30 | $42 |
| 2019-06-30 | $43 |
| 2019-03-31 | $37 |
| 2018-12-31 | $43 |
| 2018-09-30 | $38 |
| 2018-06-30 | $42 |
| 2018-03-31 | $46 |
| 2017-12-31 | $48 |
| 2017-09-30 | $36 |
| 2017-06-30 | $37 |
| 2017-03-31 | $40 |
| 2016-12-31 | $36 |
| 2016-09-30 | $38 |
| 2016-06-30 | $38 |
| 2016-03-31 | $43 |
| 2015-12-31 | $56 |
| 2015-09-30 | $41 |
| 2015-06-30 | $37 |
| 2015-03-31 | $39 |
| 2014-12-31 | $40 |
| 2014-09-30 | $35 |
| 2014-06-30 | $32 |
| 2014-03-31 | $32 |
| 2013-12-31 | $32 |
| 2013-09-30 | $30 |
| 2013-06-30 | $11 |
| 2013-03-31 | $29 |
| 2012-12-31 | $29 |
| 2012-09-30 | $27 |
| 2012-06-30 | $31 |
| 2012-03-31 | $28 |
| 2011-12-31 | $24 |
| 2011-09-30 | $27 |
| 2011-06-30 | $24 |
| 2011-03-31 | $23 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.941B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.481B | 82.12 |
| Thermo Fisher Scientific (TMO) | United States | $152.647B | 18.46 |
| Edwards Lifesciences (EW) | United States | $44.494B | 29.17 |
| Alcon (ALC) | Switzerland | $43.016B | 29.07 |
| IDEXX Laboratories (IDXX) | United States | $42.664B | 49.03 |
| DexCom (DXCM) | United States | $34.337B | 53.07 |
| IQVIA Holdings (IQV) | United States | $27.434B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.631B | 29.29 |
| STERIS (STE) | Ireland | $23.569B | 25.96 |
| Waters (WAT) | United States | $20.638B | 29.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.019B | 0.00 |
| Hologic (HOLX) | United States | $14.447B | 15.70 |
| Sysmex ADR (SSMXY) | Japan | $10.802B | 30.64 |
| Penumbra (PEN) | United States | $9.903B | 77.73 |
| Masimo (MASI) | United States | $9.232B | 34.05 |
| Glaukos (GKOS) | United States | $5.725B | 0.00 |
| Teleflex (TFX) | United States | $5.307B | 8.76 |
| TransMedics (TMDX) | United States | $4.486B | 97.53 |
| Integer Holdings (ITGR) | United States | $4.202B | 22.01 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.510B | 14.94 |
| Veracyte (VCYT) | United States | $2.105B | 29.54 |
| Nihon Kohden (NHNKY) | Japan | $1.997B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.44 |
| Pulse Biosciences (PLSE) | United States | $1.036B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.769B | 39.02 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| RxSight (RXST) | United States | $0.557B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.61 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| AxoGen (AXGN) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.372B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| NeuroPace (NPCE) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.61 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Neuronetics (STIM) | United States | $0.233B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.89 |